Literature DB >> 28492239

Reductions in blood pressure during a community-based overweight and obesity treatment in children and adolescents with prehypertension and hypertension.

P M Mollerup1, U Lausten-Thomsen1, C E Fonvig1,2, J L Baker2,3, J-C Holm1,2,4.   

Abstract

Due to the pandemic of childhood obesity and thus obesity-related hypertension, improvements in treatment availability are needed. Hence, we investigated whether reductions in blood pressure (BP) would occur in children with overweight and obesity exhibiting prehypertension/hypertension during a community-based overweight and obesity treatment program, and if changes in body mass index (BMI) are associated with changes in BP. The study included 663 children aged 3-18 years with a BMI ⩾85th percentile for sex and age that entered treatment from June 2012 to January 2015. Height, weight and BP were measured upon entry and every 3-6 months. BMI and BP s.d. scores (SDSs) were calculated according to sex and age, or sex, age and height. Prehypertension was defined as a BP SDS ⩾1.28 and <1.65. Hypertension was defined as a BP SDS ⩾1.65. Upon entry, 52% exhibited prehypertension (11.9%) or exhibited hypertension (40.1%). After 12 months (range: 3-29) of treatment, 29.3% of the children with prehypertension/hypertension were normotensive. Children with systolic prehypertension/hypertension upon entry reduced their systolic BP SDSs by 0.31 (95% confidence interval (CI): 0.70-0.83, P<0.0001). Children with diastolic prehypertension/hypertension upon entry reduced their diastolic BP SDSs by 0.78 (95% CI: 0.78-0.86, P<0.0001). BMI SDS changes were positively associated with BP SDS changes (P<0.0001). Nonetheless, some children reduced BP SDSs while increasing their BMI SDSs, and prehypertension/hypertension developed in 23.3% of the normotensive children despite reductions in BMI SDSs (P<0.0001). These results suggest that community-based overweight and obesity treatment can reduce BP, and thus may help improve treatment availability.

Entities:  

Mesh:

Year:  2017        PMID: 28492239     DOI: 10.1038/jhh.2017.36

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  33 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 2.  Office, ambulatory and home blood pressure measurement in children and adolescents.

Authors:  Nikos Karpettas; Anastasios Kollias; Andriani Vazeou; George S Stergiou
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-11

3.  White coat hypertension in childhood: evidence for end-organ effect.

Authors:  Rae-Ellen W Kavey; Daniel A Kveselis; Nader Atallah; Frank C Smith
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

4.  Two-year outcomes of an adjunctive telephone coaching and electronic contact intervention for adolescent weight-loss maintenance: the Loozit randomized controlled trial.

Authors:  B Nguyen; V A Shrewsbury; J O'Connor; K S Steinbeck; A J Hill; S Shah; M R Kohn; S Torvaldsen; L A Baur
Journal:  Int J Obes (Lond)       Date:  2012-05-15       Impact factor: 5.095

5.  Validation of the Omron 705 IT oscillometric device for home blood pressure measurement in children and adolescents: the Arsakion School Study.

Authors:  George S Stergiou; Nikolaos G Yiannes; Vayia C Rarra
Journal:  Blood Press Monit       Date:  2006-08       Impact factor: 1.444

6.  Health-related quality of life of severely obese children and adolescents.

Authors:  Jeffrey B Schwimmer; Tasha M Burwinkle; James W Varni
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

7.  Variations in pattern of pubertal changes in girls.

Authors:  W A Marshall; J M Tanner
Journal:  Arch Dis Child       Date:  1969-06       Impact factor: 3.791

8.  Prevalence, persistence, and clinical significance of masked hypertension in youth.

Authors:  Empar Lurbe; Isabel Torro; Vicente Alvarez; Tim Nawrot; Rafael Paya; Josep Redon; Jan A Staessen
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

9.  Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence.

Authors:  Thomas Reinehr; Michaela Kleber; Andre Michael Toschke
Journal:  Atherosclerosis       Date:  2009-04-05       Impact factor: 5.162

10.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

Authors:  G S Berenson; S R Srinivasan; W Bao; W P Newman; R E Tracy; W A Wattigney
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

View more
  4 in total

1.  Longitudinal evaluation of an mHealth overweight and obesity management tool.

Authors:  Ida Olivia Juhl Langkjær; Cilius Esmann Fonvig; Louise Aas Holm; Andreas Friis Pihl; Jens-Christian Holm
Journal:  Mhealth       Date:  2022-01-20

2.  Hypertension in obese children is associated with vitamin D deficiency and serotonin dysregulation.

Authors:  Katarína Krivošíková; Zora Krivošíková; Ladislava Wsolová; Tomáš Seeman; Ľudmila Podracká
Journal:  BMC Pediatr       Date:  2022-05-17       Impact factor: 2.567

3.  ATP2B1 gene polymorphisms rs2681472 and rs17249754 are associated with susceptibility to hypertension and blood pressure levels: A systematic review and meta-analysis.

Authors:  Ming Xie; Shuqian Yuan; Yuan Zeng; Chanjuan Zheng; Yide Yang; Yanhui Dong; Quanyuan He
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

4.  Effects of added salt reduction on central and peripheral blood pressure.

Authors:  Ana Carolina Arantes; Ana Luiza Lima Sousa; Priscila Valverde de O Vitorino; Paulo Cesar B Veiga Jardim; Thiago de Souza Veiga Jardim; Jeeziane Marcelino Rezende; Ellen de Souza Lelis; Rafaela Bernardes Rodrigues; Antonio Coca; Weimar Kunz Sebba Barroso
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.